BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1740460)

  • 21. Structure/function analyses of recombinant variants of human factor Xa: factor Xa incorporation into prothrombinase on the thrombin-activated platelet surface is not mimicked by synthetic phospholipid vesicles.
    Larson PJ; Camire RM; Wong D; Fasano NC; Monroe DM; Tracy PB; High KA
    Biochemistry; 1998 Apr; 37(14):5029-38. PubMed ID: 9538022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phosphatidylserine binding alters the conformation and specifically enhances the cofactor activity of bovine factor Va.
    Zhai X; Srivastava A; Drummond DC; Daleke D; Lentz BR
    Biochemistry; 2002 Apr; 41(17):5675-84. PubMed ID: 11969429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional properties of recombinant factor V mutated in a potential calcium-binding site.
    Sørensen KW; Nicolaes GA; Villoutreix BO; Yamazaki T; Tans G; Rosing J; Dahlbäck B
    Biochemistry; 2004 May; 43(19):5803-10. PubMed ID: 15134454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The contribution of bovine Factor V and Factor Va to the activity of prothrombinase.
    Nesheim ME; Taswell JB; Mann KG
    J Biol Chem; 1979 Nov; 254(21):10952-62. PubMed ID: 500617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The preparation and phospholipid binding property of the C2 domain of human factor VIII.
    Takeshima K; Smith C; Tait J; Fujikawa K
    Thromb Haemost; 2003 May; 89(5):788-94. PubMed ID: 12719774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and characterization of a phospholipid-binding site of bovine factor Va.
    Kalafatis M; Jenny RJ; Mann KG
    J Biol Chem; 1990 Dec; 265(35):21580-9. PubMed ID: 2254316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human neutrophil elastase activates human factor V but inactivates thrombin-activated human factor V.
    Samis JA; Garrett M; Manuel RP; Nesheim ME; Giles AR
    Blood; 1997 Aug; 90(3):1065-74. PubMed ID: 9242537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Location of the multimerin 1 binding site in coagulation factor V: an update.
    Jeimy SB; Quinn-Allen MA; Fuller N; Kane WH; Hayward CP
    Thromb Res; 2008; 123(2):352-4. PubMed ID: 18452976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms that regulate the anticoagulant function of coagulation factor V.
    Thorelli E
    Scand J Clin Lab Invest Suppl; 1999; 229():19-26. PubMed ID: 10097286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural investigation of the A domains of human blood coagulation factor V by molecular modeling.
    Villoutreix BO; Dahlbäck B
    Protein Sci; 1998 Jun; 7(6):1317-25. PubMed ID: 9655335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Construction, expression, and characterization of a chimera of factor IX and factor X. The role of the second epidermal growth factor domain and serine protease domain in factor Va binding.
    Hertzberg MS; Ben-Tal O; Furie B; Furie BC
    J Biol Chem; 1992 Jul; 267(21):14759-66. PubMed ID: 1634519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cleavage requirements for activation of factor V by factor Xa.
    Thorelli E; Kaufman RJ; Dahlbäck B
    Eur J Biochem; 1997 Jul; 247(1):12-20. PubMed ID: 9249003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombin-catalyzed activation of recombinant human factor V.
    Keller FG; Ortel TL; Quinn-Allen MA; Kane WH
    Biochemistry; 1995 Mar; 34(12):4118-24. PubMed ID: 7696276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of factor VIII by thrombin increases its affinity for binding to synthetic phospholipid membranes and activated platelets.
    Saenko EL; Scandella D; Yakhyaev AV; Greco NJ
    J Biol Chem; 1998 Oct; 273(43):27918-26. PubMed ID: 9774404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prothrombin activation by an activator from the venom of Oxyuranus scutellatus (Taipan snake).
    Speijer H; Govers-Riemslag JW; Zwaal RF; Rosing J
    J Biol Chem; 1986 Oct; 261(28):13258-67. PubMed ID: 3531198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phospholipid vesicles interfere with the binding of antibody fragments to the light chain of factor VIII.
    Lewis DA; Bovenschen N; Mertens K; Voorberg J; Ortel TL
    Thromb Haemost; 2005 May; 93(5):833-41. PubMed ID: 15886796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assembly of the prothrombinase complex on lipid vesicles depends on the stereochemical configuration of the polar headgroup of phosphatidylserine.
    Comfurius P; Smeets EF; Willems GM; Bevers EM; Zwaal RF
    Biochemistry; 1994 Aug; 33(34):10319-24. PubMed ID: 8068668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ca2+ binding to the first epidermal growth factor-like domain of human blood coagulation factor IX promotes enzyme activity and factor VIII light chain binding.
    Lenting PJ; Christophe OD; Maat H; Rees DJ; Mertens K
    J Biol Chem; 1996 Oct; 271(41):25332-7. PubMed ID: 8810297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The contribution of amino acid region ASP695-TYR698 of factor V to procofactor activation and factor Va function.
    Beck DO; Bukys MA; Singh LS; Szabo KA; Kalafatis M
    J Biol Chem; 2004 Jan; 279(4):3084-95. PubMed ID: 14559913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New insights into binding interfaces of coagulation factors V and VIII and their homologues lessons from high resolution crystal structures.
    Fuentes-Prior P; Fujikawa K; Pratt KP
    Curr Protein Pept Sci; 2002 Jun; 3(3):313-39. PubMed ID: 12188899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.